Literature DB >> 909427

Glucosidases.

G Legler.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 909427     DOI: 10.1016/s0076-6879(77)46044-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  19 in total

1.  Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher disease.

Authors:  Benjamin Liou; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2009-02-13       Impact factor: 4.797

2.  Salicortin: a repeat-attack new-mechanism-based Agrobacterium faecalis beta-glucosidase inhibitor.

Authors:  J Zhu; S G Withers; P B Reichardt; E Treadwell; T P Clausen
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.

Authors:  D Pelled; H Shogomori; A H Futerman
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

4.  Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth.

Authors:  A Schwarz; A H Futerman
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

5.  The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.

Authors:  Heinz G Körschen; Yildiz Yildiz; Diana Nancy Raju; Sophie Schonauer; Wolfgang Bönigk; Vera Jansen; Elisabeth Kremmer; U Benjamin Kaupp; Dagmar Wachten
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

6.  A new approach in the active site investigation of an inverting β-D-xylosidase from Thermobifida fusca TM51.

Authors:  Csaba Attila Fekete; László Kiss
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

7.  Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.

Authors:  G A Grabowski; T Dinur; K M Osiecki; J R Kruse; G Legler; S Gatt
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

8.  Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

Authors:  W M Holleran; Y Takagi; G K Menon; G Legler; K R Feingold; P M Elias
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  On the role of oligosaccharide trimming in the maturation of Sindbis and influenza virus.

Authors:  R Datema; P A Romero; R Rott; R T Schwarz
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.

Authors:  I Meivar-Levy; M Horowitz; A H Futerman
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.